scholarly journals Review on Hot Melt Extrusion Technology and it's Application

Author(s):  
Mali A. S. ◽  
Gavali K. V. ◽  
Choudhari R. G. ◽  
Anekar V. P. ◽  
Gavhane Y. N.

The use of hot-melt extrusion (HME) within the pharmaceutical industry is steadily increasing, due to proven its ability to efficiently manufacture novel products. With the use of HME we can increase solubility and bioavailability of the API. HME has proven to be a robust method of producing numerous drug delivery systems like modified, controlled and targeted drug delivery systems. resulting improved bioavailability as well as taste masking of bitter active pharmaceutical ingredients (APIs). Hot-melt extrusion techniques are pragmatic in the manufacture of a variety of dosage forms and formulations such as granules, pellets, tablets, suppositories, implants, stents, transdermal systems and ophthalmic inserts. In This paper we review about the types of Extruder, solid dispersion and Application of the HME to the pharmaceutical industries.

2017 ◽  
Vol 8 (11) ◽  
pp. 957-966 ◽  
Author(s):  
Marcilio Cunha-Filho ◽  
Maísa RP Araújo ◽  
Guilherme M Gelfuso ◽  
Tais Gratieri

Pharmaceutics ◽  
2021 ◽  
Vol 13 (9) ◽  
pp. 1424
Author(s):  
Juliana dos Santos ◽  
Guilherme Silveira da Silva ◽  
Maiara Callegaro Velho ◽  
Ruy Carlos Ruver Beck

Eudragit® polymers are polymethacrylates highly used in pharmaceutics for the development of modified drug delivery systems. They are widely known due to their versatility with regards to chemical composition, solubility, and swelling properties. Moreover, Eudragit polymers are thermoplastic, and their use has been boosted in some production processes, such as hot melt extrusion (HME) and fused deposition modelling 3D printing, among other 3D printing techniques. Therefore, this review covers the studies using Eudragit polymers in the development of drug delivery systems produced by HME and 3D printing techniques over the last 10 years. Eudragit E has been the most used among them, mostly to formulate immediate release systems or as a taste-masker agent. On the other hand, Eudragit RS and Eudragit L100-55 have mainly been used to produce controlled and delayed release systems, respectively. The use of Eudragit polymers in these processes has frequently been devoted to producing solid dispersions and/or to prepare filaments to be 3D printed in different dosage forms. In this review, we highlight the countless possibilities offered by Eudragit polymers in HME and 3D printing, whether alone or in blends, discussing their prominence in the development of innovative modified drug release systems.


2017 ◽  
Vol 18 (7) ◽  
pp. 2639-2647 ◽  
Author(s):  
Nicole S. Mendonsa ◽  
Priyanka Thipsay ◽  
Dong Wuk Kim ◽  
Scott T. Martin ◽  
Michael A. Repka

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Mohammed Maniruzzaman ◽  
Joshua S. Boateng ◽  
Martin J. Snowden ◽  
Dennis Douroumis

Over the last three decades industrial adaptability has allowed hot-melt extrusion (HME) to gain wide acceptance and has already established its place in the broad spectrum of manufacturing operations and pharmaceutical research developments. HME has already been demonstrated as a robust, novel technique to make solid dispersions in order to provide time controlled, modified, extended, and targeted drug delivery resulting in improved bioavailability as well as taste masking of bitter active pharmaceutical ingredients (APIs). This paper reviews the innumerable benefits of HME, based on a holistic perspective of the equipment, processing technologies to the materials, novel formulation design and developments, and its varied applications in oral drug delivery systems.


2019 ◽  
Vol 16 (6) ◽  
pp. 567-582 ◽  
Author(s):  
Sandeep Sarabu ◽  
Suresh Bandari ◽  
Venkata Raman Kallakunta ◽  
Roshan Tiwari ◽  
Hemlata Patil ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document